Africa Vaccines Market (2024-2030) | Value, Companies, Outlook, Size, Analysis, Industry, Forecast, Growth, Trends, Share, Revenue

Africa Vaccines Market Highlights

Report Name	Africa Vaccines Market
Forecast period	2024-2030
Market Size	$2.1 billion - $4.5 billion
CAGR	12%
Growing Sector	Pediatric vaccines

Topics Covered in the Africa Vaccines Market Report

Africa Vaccines Market report thoroughly covers the market By Countries, By Technology, By Type, By Disease Indication, By Route of Administration, and By Patient Type. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.

Africa Vaccines Market Size & Analysis

Africa Vaccines market has been demonstrating significant growth, with an estimated market size of USD 2.1 billion in 2023. This growth is largely attributed to the increasing demand for vaccines due to the rising prevalence of infectious diseases and the expansion of immunization programs across the continent. The market is anticipated to grow at a compound annual growth rate (CAGR) of 12% from 2024 to 2030. This expansion is supported by collaborative efforts between governments and health organizations to improve healthcare infrastructure and enhance vaccine accessibility.

Moreover, the emphasis on innovative vaccine development and distribution strategies is expected to drive the overall market, with projections indicating that the Africa Vaccines market size could exceed USD 4.5 billion by 2030. Key factors fueling this growth include advancements in biotechnology and a growing public awareness of the importance of vaccinations in disease prevention.

Africa Vaccines Market Synopsis

Africa Vaccines Market is witnessing substantial growth driven by increasing public health initiatives and investments in vaccine development. The market size is expanding as governments and organizations focus on enhancing immunization coverage to combat infectious diseases. The rise in vaccine awareness among populations is contributing to a greater demand for effective immunization strategies. Furthermore, collaboration among key stakeholders is fostering innovation in vaccine research and production. The Africa Vaccines market growth is further supported by international partnerships aimed at improving healthcare infrastructure. As the region continues to address health challenges, the market share is expected to diversify, providing opportunities for emerging players. Overall, the landscape of the industry is evolving, presenting significant prospects for investment and development.

According to 6Wresearch, the Africa Vaccines Market Size is expected to reach at a significant CAGR of 12% during the forecast period 2024-2030. Africa Vaccines market is primarily driven by a combination of factors that enhance public health and promote vaccination efforts. Increasing incidences of infectious diseases across the continent have necessitated urgent action, leading to heightened government focus and investment in healthcare infrastructure. This focus contributes significantly to the market size, as both public and private sectors collaborate to improve vaccine accessibility and affordability. Enhanced awareness regarding the importance of immunization has spurred demand, further supporting market expansion. Additionally, international partnerships and funding from organizations such as the World Health Organization (WHO) play a critical role in facilitating vaccine research and development initiatives. The rise of local manufacturing capabilities is also a key driver, ensuring that vaccines are produced in proximity to populations in need. Furthermore, technological advancements in vaccine delivery and distribution are optimizing immunization programs. The commitment to addressing health disparities is expected to result in increased market growth, providing opportunities for stakeholders to invest in innovative solutions. Overall, these drivers are shaping the future of the Africa Vaccines industry, fostering a more robust and resilient healthcare landscape across the continent.

Africa Vaccines market faces several challenges that hinder its potential growth and effectiveness in combating infectious diseases. One significant barrier is the inadequate healthcare infrastructure across many regions, which affects vaccine distribution and accessibility, limiting overall progress. Logistical issues, including supply chain disruptions and cold chain management, complicate the timely delivery of vaccines to remote areas. Furthermore, vaccine hesitancy among populations, fueled by misinformation and cultural beliefs, poses a significant obstacle to achieving widespread immunization. The reliance on imported vaccines raises concerns about sustainability and cost, impacting overall market development. Regulatory hurdles and varying standards across countries can delay vaccine approval and introduction, further complicating market dynamics. Limited funding for vaccine research and development in the region restricts innovation and local production capabilities. These challenges contribute to a complex landscape, necessitating coordinated efforts among stakeholders to develop effective strategies for overcoming them and improving public health outcomes across the continent. Addressing these obstacles is crucial for enhancing the effectiveness and reach of vaccination programs in Africa.

Africa Vaccines Market Trends

Africa Vaccines Market trends indicate a dynamic shift towards increased local manufacturing and innovation in vaccine development. With a growing emphasis on self-sufficiency, many countries are investing in the establishment of local production facilities to enhance the Africa Vaccines market size and reduce reliance on imports. This trend is further supported by partnerships with global organizations to improve research capabilities and technology transfer. Additionally, there is a significant focus on the development of vaccines targeting emerging infectious diseases, which is expected to drive market expansion.

The rise of public-private partnerships is facilitating better funding and resources for vaccine initiatives, thus enhancing overall effectiveness. Increased awareness and advocacy for vaccination programs are also contributing to changing public perceptions, encouraging higher immunization rates. Furthermore, advancements in digital health technologies are optimizing vaccine distribution and monitoring processes. Overall, these trends highlight a proactive approach within the industry to enhance vaccine accessibility and effectiveness, ultimately improving public health outcomes across the continent. The ongoing transformation in this sector is set to create new opportunities for growth and collaboration among stakeholders.

Investment Opportunities in the Africa Vaccines Market

Africa Vaccines market presents substantial investment opportunities driven by the region's commitment to improving public health outcomes. As the market size continues to expand, investors are increasingly attracted to local manufacturing initiatives aimed at enhancing vaccine accessibility and reducing dependency on imports. The push for self-sufficiency in vaccine production is further supported by government incentives and partnerships with international organizations, creating a favorable environment for investment. Additionally, the growing demand for innovative vaccines addressing emerging infectious diseases highlights a critical area for research and development funding.

Investments in supply chain optimization and cold chain logistics are also essential to ensure effective vaccine distribution, particularly in remote areas. Furthermore, technological advancements in vaccine delivery and data management systems present opportunities for innovative solutions that can enhance efficiency. With the rising awareness of vaccination benefits and increased public support for immunization programs, the Africa Vaccines market growth trajectory appears promising. Overall, these factors indicate a robust landscape for potential investors seeking to capitalize on the evolving dynamics of the industry. Strategic investments in this sector are likely to yield significant returns while contributing to the region's health security

Leading Players in the Africa Vaccines Market

Africa Vaccines market is characterized by the presence of several leading players dedicated to enhancing immunization efforts across the continent. One of the prominent companies is the Serum Institute of India, which is known for its significant contributions to vaccine production and aims to supply affordable vaccines to African countries. Another key player is GSK (GlaxoSmithKline), which has a strong presence in the region, focusing on innovative vaccine solutions to combat diseases like malaria and HPV. Sanofi Pasteur also plays a crucial role, leveraging its extensive experience to develop and distribute vaccines tailored to local health needs.

Additionally, Pfizer has made significant strides in expanding its vaccine portfolio in Africa, particularly in response to the COVID-19 pandemic, offering both traditional and mRNA vaccine options. Merck & Co. is another notable player, focusing on vaccines for infectious diseases and investing in research to enhance immunization strategies. Lastly, Bharat Biotech is emerging as a significant contributor, developing indigenous vaccines aimed at improving healthcare accessibility. These companies collectively influence the market size and contribute to its market growth by fostering innovation and expanding vaccine availability, ultimately enhancing the Africa Vaccines industry landscape.

Government Regulations

Government regulations play a pivotal role in shaping the Africa Vaccines market, ensuring the safety and efficacy of vaccines while promoting public health initiatives. Regulatory bodies, such as the African Medicines Agency (AMA), have been established to harmonize vaccine approval processes across the continent, facilitating a more efficient pathway for bringing vaccines to market. Additionally, the Africa Vaccines market size is influenced by policies such as the African Union's Agenda 2063, which emphasizes increased investment in health infrastructure and local vaccine production capabilities. Countries are also implementing stringent guidelines for vaccine storage and distribution, as outlined in the World Health Organization's (WHO) Global Vaccine Action Plan, to maintain the integrity of vaccines throughout the supply chain.

Furthermore, initiatives like the Coalition for Epidemic Preparedness Innovations (CEPI) promote rapid research and development of vaccines in response to emerging health threats, significantly impacting the market growth. By creating a robust regulatory framework, governments aim to enhance vaccine accessibility and affordability, thereby improving overall public health outcomes. These regulations are crucial for fostering trust in vaccination programs and ensuring that the industry continues to evolve sustainably.

Future Insights of the Africa Vaccines Market

Africa Vaccines market is poised for significant evolution in the coming years, driven by advancements in technology and increasing collaboration among stakeholders. The market size is expected to expand as local manufacturing capabilities improve, reducing reliance on imported vaccines and enhancing self-sufficiency. Innovations in vaccine delivery systems, such as mobile health applications and digital tracking, are anticipated to optimize immunization programs and improve access to vaccines in remote areas. Furthermore, growing investment in research and development will likely lead to the emergence of new vaccines targeting infectious diseases prevalent in the region.

Increased public awareness and advocacy for vaccination will further contribute to the market's expansion, fostering higher immunization rates. Additionally, the ongoing partnerships between governments, international organizations, and private sector players will facilitate the sharing of resources and expertise, driving sustainable growth. As the Africa Vaccines market growth accelerates, it will attract new entrants and investment opportunities, ultimately strengthening the overall healthcare landscape. The focus on equitable vaccine distribution and addressing health disparities will also shape the future of the industry, ensuring that all populations benefit from advancements in immunization.

Market Segmentation Analysis 

The report offers a comprehensive study of the subsequent market segments and their leading categories. 

Nigeria to Dominate the Market- By Countries

Nigeria is experiencing significant growth in the Africa Vaccines Market, driven by increased government initiatives and public health campaigns. The country's efforts to enhance vaccination coverage and tackle preventable diseases have garnered substantial attention. As awareness of vaccine importance rises, Nigeria's market is poised for further expansion in the coming years.

Recombinant vaccines to Dominate the Market-By Technology

According to Vasudha, Senior Research Analyst, 6Wresearch, Recombinant vaccines are currently experiencing significant growth. This trend is driven by advancements in biotechnology, increasing demand for more effective and safer vaccines, and the need for rapid responses to emerging infectious diseases. 

Multivalent Vaccines to Dominate the Market- By Type

Multivalent vaccines are the category that is currently experiencing significant growth. This growth can be attributed to their ability to target multiple pathogens or strains with a single vaccine, which is particularly beneficial in regions facing a high burden of infectious diseases. Multivalent vaccines help streamline immunization programs and improve coverage, contributing to their increasing popularity and demand across the continent.

HPV to Dominate the Market- By Disease Indication

HPV vaccines are witnessing significant growth in the Africa vaccine market. This trend is driven by increased awareness of cervical cancer prevention and the implementation of national vaccination programs targeting adolescent girls. As public health initiatives expand, HPV vaccination rates are expected to rise, contributing to improved health outcomes across the region.

Oral administration to Dominate the Market- By Route of Administration

Oral administration is the growing category by Route of Administration. This growth can be attributed to the increased focus on ease of administration, particularly in pediatric populations, as well as efforts to improve vaccination coverage and accessibility in rural and underserved areas. Oral vaccines are generally more user-friendly and can help in enhancing immunization rates, making them an attractive option for health initiatives across the continent.

Pediatric patients to Dominate the Market- By Patient Type

Pediatric patients category is experiencing significant growth. This growth is primarily driven by increasing vaccination programs aimed at children, heightened awareness of vaccine-preventable diseases, and government initiatives to improve child health. Additionally, the rising prevalence of diseases affecting children, such as pneumonia and rotavirus, further supports this trend.

Key Attractiveness of the Report

• 10 Years of Market Numbers.
• Historical Data Starting from 2020 to 2023.
• Base Year: 2023
• Forecast Data until 2030.
• Key Performance Indicators Impacting the Market.
• Major Upcoming Developments and Projects.

Key Highlights of the Report

• Africa Vaccines Market Outlook
• Market Size of Africa Vaccines Market, 2023
• Forecast of Africa Vaccines Market, 2030
• Historical Data and Forecast of Africa Vaccines Revenues & Volume for the Period 2020 - 2030
• Africa Vaccines Market Trend Evolution
• Africa Vaccines Market Drivers and Challenges
• Africa Vaccines Price Trends
• Africa Vaccines Porter's Five Forces
• Africa Vaccines Industry Life Cycle
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Technology for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Technology for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Technology for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Technology for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Technology for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Type for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Type for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Type for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Type for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Type for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Disease Indication for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By DTP for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Influenza for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By HPV for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Polio for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Rotavirus for the Period 2020 - 2030
• Historical Data and Forecast of Africa Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Disease Indication for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By DTP for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Influenza for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By HPV for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Polio for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Rotavirus for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Disease Indication for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By DTP for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Influenza for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By HPV for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Polio for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Rotavirus for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Disease Indication for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By DTP for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Influenza for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By HPV for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Polio for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Rotavirus for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Disease Indication for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By DTP for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Influenza for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By HPV for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Polio for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Rotavirus for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Route of Administration for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Oral administration for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Other routes of administration for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Route of Administration for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Oral administration for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Other routes of administration for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Route of Administration for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Oral administration for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Other routes of administration for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Route of Administration for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Oral administration for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Other routes of administration for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Route of Administration for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Oral administration for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Other routes of administration for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Patient Type for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Pediatric patients for the Period 2020 - 2030
• Historical Data and Forecast of Africa Vaccines Market Revenues & Volume By Adult patients for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Patient Type for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Pediatric patients for the Period 2020 - 2030
• Historical Data and Forecast of South Africa Vaccines Market Revenues & Volume By Adult patients for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Patient Type for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Pediatric patients for the Period 2020 - 2030
• Historical Data and Forecast of Nigeria Vaccines Market Revenues & Volume By Adult patients for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Patient Type for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Pediatric patients for the Period 2020 - 2030
• Historical Data and Forecast of Kenya Vaccines Market Revenues & Volume By Adult patients for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Patient Type for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Pediatric patients for the Period 2020 - 2030
• Historical Data and Forecast of Rest of Africa Vaccines Market Revenues & Volume By Adult patients for the Period 2020 - 2030
• Africa Vaccines Market - Key Performance Indicators
• Africa Vaccines Market - Import Export Trade Statistics
• Africa Vaccines Market - Opportunity Assessment By Countries
• Africa Vaccines Market - Opportunity Assessment By Technology
• Africa Vaccines Market - Opportunity Assessment By Type
• Africa Vaccines Market - Opportunity Assessment By Disease Indication
• Africa Vaccines Market - Opportunity Assessment By Route of Administration
• Africa Vaccines Market - Opportunity Assessment By Patient Type
• Africa Vaccines Market - Top Companies Market Share
• Africa Vaccines Market - Top Companies Profiles
• Africa Vaccines Market - Comparison of Players in Technical and Operating Parameters
• Africa Vaccines Market - Strategic Recommendations

Market Covered

The market report has been segmented and sub segmented into the following categories: 

By Countries

• South Africa
  
• Nigeria
  
• Kenya
  
• Rest of Africa

By Technology

• Conjugate vaccines
  
• Inactivated and subunit vaccines
  
• Live attenuated vaccines
  
• Recombinant vaccines
  
• Toxoid vaccines

By Type

• Monovalent vaccines
  
• Multivalent vaccines

By Disease Indication

• Pneumococcal disease
  
• DTP
  
• Influenza
  
• HPV
  
• Meningococcal disease
  
• Polio
  
• Rotavirus
  
• Other disease indications

By Route of Administration

• Intramuscular and subcutaneous administration
  
• Oral administration
  
• Other routes of administration

By Patient Type

• Pediatric patients
  
• Adult patients